Cangrelor for ST-Segment-Elevation Myocardial Infarction Pharmocodynamic Evidence Is In

被引：2
|
作者：
Erlinge, David [1 ]
机构：
[1] Lund Univ, Dept Cardiol, Clin Sci, Skane Univ Hosp Lund, Lund, Sweden
来源：
CIRCULATION | 2019年 / 139卷 / 14期
关键词：
Editorials; percutaneous coronary intervention; pharmacology; purinergic P2Y receptor antagonists; ST elevation myocardial infarction; stents; thrombosis; GLYCOPROTEIN IIB/IIIA INHIBITORS; PLATELET INHIBITION;
D O I：
10.1161/CIRCULATIONAHA.119.039253
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1671 / 1673
页数：3
相关论文
共 50 条
  • [31] Timing of Mortality After Severe Bleeding and Recurrent Myocardial Infarction in Patients With ST-Segment-Elevation Myocardial Infarction
    Kikkert, Wouter J.
    Zwinderman, Aeilko H.
    Vis, Marije M.
    Baan, Jan, Jr.
    Koch, Karel T.
    Peters, Ron J.
    de Winter, Robbert J.
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (04) : 391 - 398
  • [32] Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI
    Paradossi, Umberto
    Taglieri, Nevio
    Massarelli, Giulia
    Palmieri, Cataldo
    De Caterina, Alberto Ranieri
    Bruno, Antonio Giulio
    Taddei, Alessandro
    Nardi, Elena
    Ghetti, Gabriele
    Palmerini, Tullio
    Trianni, Giuseppe
    Mazzone, Annamaria
    Pizzi, Carmine
    Donati, Francesco
    Bendandi, Francesco
    Marrozzini, Cinzia
    Ravani, Marcello
    Galie, Nazzareno
    Saia, Francesco
    Berti, Sergio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2022, 23 (04) : 234 - 241
  • [33] Hypothermia and its role in patients with ST-segment-elevation myocardial infarction and cardiac arrest
    Keller, Karsten
    Sagoschen, Ingo
    Schmitt, Volker H.
    Muenzel, Thomas
    Gori, Tommaso
    Hobohm, Lukas
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [34] Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment-Elevation Myocardial Infarction
    Miedema, Michael D.
    Newell, Marc C.
    Duval, Sue
    Garberich, Ross F.
    Handran, Chauncy B.
    Larson, David M.
    Mulder, Steven
    Wang, Yale L.
    Lips, Daniel L.
    Henry, Timothy D.
    CIRCULATION, 2011, 124 (15) : 1636 - 1644
  • [35] Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction Primary Results of the FABOLUS-FASTER Trial
    Gargiulo, Giuseppe
    Esposito, Giovanni
    Avvedimento, Marisa
    Nagler, Michael
    Minuz, Pietro
    Campo, Gianluca
    Gragnano, Felice
    Manavifar, Negar
    Piccolo, Raffaele
    Tebaldi, Matteo
    Cirillo, Plinio
    Hunziker, Lukas
    Vranckx, Pascal
    Leonardi, Sergio
    Heg, Dik
    Windecker, Stephan
    Valgimigli, Marco
    CIRCULATION, 2020, 142 (05) : 441 - 454
  • [36] Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction
    Abo-Aly, Mohamed
    George, Bennet
    Shokri, Elica
    Chelvarajan, Lakshman
    El-Helw, Mohamed
    Smyth, Susan S.
    Abdel-Latif, Ahmed
    Ziada, Khaled
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 934 - 940
  • [37] What can we find in QRS in patients with ST-segment-elevation myocardial infarction?
    Yang, Na
    Han, Xiaorong
    Zhang, Jin
    Zhang, Shuai
    Sun, Jian
    JOURNAL OF ELECTROCARDIOLOGY, 2022, 75 : 52 - 59
  • [38] Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction
    Biswas, Sinjini
    Andrianopoulos, Nick
    Duffy, Stephen J.
    Lefkovits, Jeffrey
    Brennan, Angela
    Walton, Antony
    Chan, William
    Noaman, Samer
    Shaw, James A.
    Ajani, Andrew
    Clark, David J.
    Freeman, Melanie
    Hiew, Chin
    Oqueli, Ernesto
    Reid, Christopher M.
    Stub, Dion
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2019, 12 (01): : e004979
  • [39] Interplay Between Time of Presentation, Timeliness of Reperfusion, and Outcome After ST-Segment-Elevation Myocardial Infarction
    Jneid, Hani
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (05): : 637 - 639
  • [40] Long-Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST-Segment-Elevation Myocardial Infarction
    Cassese, Salvatore
    Kastrati, Adnan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
12345